D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 73 Citations 27,064 167 World Ranking 13365 National Ranking 196

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Diabetes mellitus

The scientist’s investigation covers issues in Internal medicine, Endocrinology, Type 2 diabetes, Diabetes mellitus and Immunology. His Internal medicine research includes themes of Downregulation and upregulation and Surgery. His work carried out in the field of Endocrinology brings together such families of science as Apoptosis and Programmed cell death.

As part of the same scientific family, Marc Y. Donath usually focuses on Type 2 diabetes, concentrating on Autoimmunity and intersecting with Pancreatic hormone. His research investigates the link between Diabetes mellitus and topics such as Interleukin 1 receptor antagonist that cross with problems in Glycated hemoglobin, Glucose tolerance test, Intention-to-treat analysis and Anakinra. His Immunology research is multidisciplinary, incorporating perspectives in MEDLINE and Bioinformatics.

His most cited work include:

  • Type 2 diabetes as an inflammatory disease. (2071 citations)
  • Interleukin-1-receptor antagonist in type 2 diabetes mellitus. (1385 citations)
  • Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets (1000 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Internal medicine, Endocrinology, Type 2 diabetes, Diabetes mellitus and Insulin. His study ties his expertise on Gastroenterology together with the subject of Internal medicine. As a part of the same scientific study, Marc Y. Donath usually deals with the Endocrinology, concentrating on Apoptosis and frequently concerns with Cell biology.

His Type 2 diabetes study incorporates themes from Cell, Interleukin 1 receptor antagonist, Obesity and Inflammation, Immunology. His study connects Adverse effect and Diabetes mellitus. His Insulin research is multidisciplinary, incorporating elements of Paracrine signalling, Glucagon-like peptide-1 and Postprandial Hypoglycemia.

He most often published in these fields:

  • Internal medicine (76.28%)
  • Endocrinology (65.58%)
  • Type 2 diabetes (43.26%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (76.28%)
  • Endocrinology (65.58%)
  • Type 2 diabetes (43.26%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Internal medicine, Endocrinology, Type 2 diabetes, Diabetes mellitus and Anakinra. He works mostly in the field of Internal medicine, limiting it down to topics relating to Gastroenterology and, in certain cases, Insulin secretion and Hypoparathyroidism, as a part of the same area of interest. His Endocrinology research incorporates themes from Receptor and Placenta.

His Type 2 diabetes research incorporates elements of Cancer research, Inflammation, Beta, Insulin resistance and Antibody. His biological study spans a wide range of topics, including Retrospective cohort study, Immunology and Pharmacology. His studies in Anakinra integrate themes in fields like Empagliflozin and Receptor antagonist.

Between 2018 and 2021, his most popular works were:

  • Targeting innate immune mediators in type 1 and type 2 diabetes. (65 citations)
  • Targeting innate immune mediators in type 1 and type 2 diabetes. (65 citations)
  • Inflammation in the Pathophysiology and Therapy of Cardiometabolic Disease. (21 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Diabetes mellitus

His main research concerns Internal medicine, Type 2 diabetes, Tocilizumab, Diabetes mellitus and Endocrinology. With his scientific publications, his incorporates both Internal medicine and Crossover study. The Type 2 diabetes study combines topics in areas such as Inflammation and Pathogenesis.

His studies deal with areas such as Sitagliptin, Glucagon-like peptide-1, Pharmacology and Glucose homeostasis as well as Tocilizumab. His work carried out in the field of Diabetes mellitus brings together such families of science as Innate immune system, Disease, Immunology and Immunity. The concepts of his Endocrinology study are interwoven with issues in Interleukin, Interleukin 1 receptor antagonist and Antagonism.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Type 2 diabetes as an inflammatory disease.

Marc Y. Donath;Steven E. Shoelson.
Nature Reviews Immunology (2011)

3034 Citations

Interleukin-1-receptor antagonist in type 2 diabetes mellitus.

Claus M Larsen;Mirjam Faulenbach;Allan Vaag;Allan Vaag;Aage Vølund.
The New England Journal of Medicine (2007)

1821 Citations

Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets

Kathrin Maedler;Pavel Sergeev;Frédéric Ris;José Oberholzer.
Journal of Clinical Investigation (2002)

1451 Citations

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

Paul M Ridker;Jean G MacFadyen;Tom Thuren;Brendan M Everett.
The Lancet (2017)

774 Citations

Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells

Helga Ellingsgaard;Irina Hauselmann;Beat Schuler;Abdella M Habib.
Nature Medicine (2011)

717 Citations

Increased Number of Islet-Associated Macrophages in Type 2 Diabetes

Jan A. Ehses;Aurel Perren;Elisabeth Eppler;Pascale Ribaux.
Diabetes (2007)

703 Citations

Distinct Effects of Saturated and Monounsaturated Fatty Acids on β-Cell Turnover and Function

K. Maedler;G.A. Spinas;D. Dyntar;W. Moritz.
Diabetes (2001)

685 Citations

Monounsaturated Fatty Acids Prevent the Deleterious Effects of Palmitate and High Glucose on Human Pancreatic β-Cell Turnover and Function

Kathrin Maedler;José Oberholzer;Pascal Alain Robert Bucher;Giatgen A Spinas.
Diabetes (2003)

631 Citations

Targeting inflammation in the treatment of type 2 diabetes: time to start

Marc Y. Donath.
Nature Reviews Drug Discovery (2014)

575 Citations

Inflammatory mediators and islet β-cell failure: a link between type 1 and type 2 diabetes

Marc Y. Donath;Joachim Størling;Kathrin Maedler;Thomas Mandrup-Poulsen;Thomas Mandrup-Poulsen.
Journal of Molecular Medicine (2003)

572 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Marc Y. Donath

Charles A. Dinarello

Charles A. Dinarello

University of Colorado Denver

Publications: 96

Thomas Mandrup-Poulsen

Thomas Mandrup-Poulsen

University of Copenhagen

Publications: 92

Piero Marchetti

Piero Marchetti

University of Pisa

Publications: 61

Paul M. Ridker

Paul M. Ridker

Harvard Medical School

Publications: 47

Christian Herder

Christian Herder

Heinrich Heine University Düsseldorf

Publications: 47

Mihai G. Netea

Mihai G. Netea

Radboud University Nijmegen

Publications: 42

Michael Roden

Michael Roden

Heinrich Heine University Düsseldorf

Publications: 38

Alvin C. Powers

Alvin C. Powers

Vanderbilt University Medical Center

Publications: 35

Daniel J. Drucker

Daniel J. Drucker

Lunenfeld-Tanenbaum Research Institute

Publications: 33

Decio L. Eizirik

Decio L. Eizirik

Université Libre de Bruxelles

Publications: 33

Alberto Mantovani

Alberto Mantovani

Humanitas University

Publications: 32

Per-Olof Berggren

Per-Olof Berggren

Karolinska Institute

Publications: 31

Rohit N. Kulkarni

Rohit N. Kulkarni

Brigham and Women's Hospital

Publications: 30

Leo A. B. Joosten

Leo A. B. Joosten

Radboud University Nijmegen

Publications: 30

Mark A. Febbraio

Mark A. Febbraio

Monash University

Publications: 30

Bente Klarlund Pedersen

Bente Klarlund Pedersen

University of Copenhagen

Publications: 29

Trending Scientists

Eleni Stroulia

Eleni Stroulia

University of Alberta

Eli Brenner

Eli Brenner

Vrije Universiteit Amsterdam

John M. Abowd

John M. Abowd

United States Census Bureau

Constantinos A. Balaras

Constantinos A. Balaras

National and Kapodistrian University of Athens

Brian A. Maurer

Brian A. Maurer

Michigan State University

Marc J. Weissburg

Marc J. Weissburg

Georgia Institute of Technology

David J. Beech

David J. Beech

University of Leeds

Jan Carlstedt-Duke

Jan Carlstedt-Duke

Nanyang Technological University

Tomoo Shimada

Tomoo Shimada

Kyoto University

Francisca Martínez-Ruiz

Francisca Martínez-Ruiz

Spanish National Research Council

Anna Avila

Anna Avila

Autonomous University of Barcelona

Peter Vajkoczy

Peter Vajkoczy

Charité - University Medicine Berlin

Prakash Deedwania

Prakash Deedwania

University of California, San Francisco

Mario Rizzetto

Mario Rizzetto

University of Turin

Morten H. Vatn

Morten H. Vatn

University of Oslo

Sarah Lichtenstein

Sarah Lichtenstein

Oregon Research Institute

Something went wrong. Please try again later.